4D-150 IVT (3E10 vg/eye)
4D-150-C003
Phase 3 mab active
Quick answer
4D-150 IVT (3E10 vg/eye) for Macular Neovascularization Secondary to Age-Related Macular Degeneration is a Phase 3 program (mab) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Phase
- Phase 3
- Modality
- mab
- Status
- active